- Home
- INTT vs PLRX Comparison
INTT vs PLRX Comparison
Compare INTT & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTT
- PLRX
- Stock Information
- Founded
- INTT 1981
- PLRX 2015
- Country
- INTT United States
- PLRX United States
- Employees
- INTT N/A
- PLRX N/A
- Industry
- INTT Semiconductors
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- INTT Technology
- PLRX Health Care
- Exchange
- INTT Nasdaq
- PLRX Nasdaq
- Market Cap
- INTT 77.3M
- PLRX 84.7M
- IPO Year
- INTT 1997
- PLRX 2020
- Fundamental
- Price
- INTT $6.31
- PLRX $1.44
- Analyst Decision
- INTT Strong Buy
- PLRX Hold
- Analyst Count
- INTT 2
- PLRX 10
- Target Price
- INTT $12.00
- PLRX $9.79
- AVG Volume (30 Days)
- INTT 45.7K
- PLRX 987.6K
- Earning Date
- INTT 05-02-2025
- PLRX 05-08-2025
- Dividend Yield
- INTT N/A
- PLRX N/A
- EPS Growth
- INTT N/A
- PLRX N/A
- EPS
- INTT N/A
- PLRX N/A
- Revenue
- INTT $127,503,000.00
- PLRX N/A
- Revenue This Year
- INTT N/A
- PLRX N/A
- Revenue Next Year
- INTT $10.07
- PLRX N/A
- P/E Ratio
- INTT N/A
- PLRX N/A
- Revenue Growth
- INTT 5.19
- PLRX N/A
- 52 Week Low
- INTT $5.24
- PLRX $1.10
- 52 Week High
- INTT $11.92
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- INTT 53.82
- PLRX 50.02
- Support Level
- INTT $6.05
- PLRX $1.22
- Resistance Level
- INTT $6.50
- PLRX $1.41
- Average True Range (ATR)
- INTT 0.27
- PLRX 0.10
- MACD
- INTT 0.05
- PLRX 0.02
- Stochastic Oscillator
- INTT 77.91
- PLRX 78.57
About INTT inTest Corporation
inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.